BNP Paribas Financial Markets
CAI icon

BNP Paribas Financial Markets’s Caris Life Sciences CAI Stock Holding History

BNP Paribas Financial Markets’s Portfolio CAI Stock Details CAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$42.2M Buy
2,370,268
+755,982
+47% +$13.5M 0.01% 852
2026
Q1 		$28.9M Buy
1,614,286
+928,460
+135% +$20.3M 0.01% 947
2025
Q4 		$18.5M Buy
685,826
+684,626
+57,052% +$19.3M 0.01% 1231
2025
Q3 		$36.3K Buy
+1,200
New +$38.3K ﹤0.01% 4727

Other funds holding CAI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JHWEPV
J. H. Whitney Equity Partners VI New Canaan, Connecticut $201M AUM
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
SSP
Sixth Street Partners Dallas, Texas $579M AUM 2.46% 1-Year Est. Return
PointState Capital
PointState Capital New York $7.82B AUM 43.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

BNP Paribas Financial Markets's CAI Position: Q2 2026 in Review

BNP Paribas Financial Markets increased its Caris Life Sciences (CAI) stake by 47% in Q2 2026, buying an estimated $13.5M and bringing the position to 2,370,268 shares worth $42.2M. The position accounts for 0.01% of the portfolio, ranked #852.

BNP Paribas Financial Markets first reported a position in CAI in Q3 2025 and has held it in 4 quarters since. 247 funds tracked by Wall St. Rank hold CAI as of Q2 2026.

  • BNP Paribas Financial Markets held 2,370,268 shares of Caris Life Sciences worth $42.2M as of Q2 2026.
  • BNP Paribas Financial Markets bought 755,982 Caris Life Sciences shares in Q2 2026, an estimated $13.5M.
  • Caris Life Sciences made up 0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #852 holding.
  • BNP Paribas Financial Markets first reported a position in Caris Life Sciences in Q3 2025 and has held it in 4 quarters since.
  • 247 funds tracked by Wall St. Rank held Caris Life Sciences as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.